A Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure (CUPID-2b)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01643330
Recruitment Status : Completed
First Posted : July 18, 2012
Last Update Posted : March 24, 2016
Information provided by (Responsible Party):
Celladon Corporation

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2015
  Actual Study Completion Date : February 2016
  Certification/Extension First Submitted : July 24, 2015
Publications of Results:
Other Publications:

Publications automatically indexed to this study by Identifier (NCT Number):